Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-07
1998-02-24
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514364, 514252, 5142275, A61K 3141, A61K 3150, A61K 3154
Patent
active
057212635
ABSTRACT:
This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula ##STR1## wherein R.sup.1 is H or an optionally substituted hydrocarbon residue; R.sup.2 is an optionally esterified carboxyl group; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R.sup.2 ; and Y is a bond, --O--, --S(O)m-- (wherein m is 0, 1 or 2) or --N(R.sup.4)-- (wherein R.sup.4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
REFERENCES:
patent: 4139633 (1979-02-01), Brunnel et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 4895846 (1990-01-01), Poindexter et al.
patent: 5128356 (1992-07-01), Naka et al.
patent: 5162326 (1992-11-01), Naka et al.
patent: 5183899 (1993-02-01), Naka et al.
patent: 5250554 (1993-10-01), Naka et al.
patent: 5284661 (1994-02-01), Morimoto et al.
"Low Doses of Hydrochlorothiazide in Hypertension Antihypertensive and Metabolic Effects", G. Berglund, et al., Europ. J. Clin. Pharmacol., vol. 10, pp. 177-182 (1976).
"Antihypertensive Effect of Various Doses of Hydrochlorothiazide and its Relation to the Plasma Level of the Drug", B. Beermann, et al., Europ. J. Clin. Pharmacol. vol. 13, pp. 195-201 (1978).
"Effects if a nonpeptide angiotensin II receptro antagonist (CV-11974) on et al., Europ. J. Of Pharmacol., vol. 235, pp. 313-316 (1993).
Martindale, The Extra Pharmacopoeia, 13th Edition ags 368 & 374, 1993.
Inada Yoshiyuki
Kubo Keiji
Dees Jos,e G.
Lambkin Deborah
Takeda Chemical Industries Ltd.
LandOfFree
Pharmaceutical composition for angiotensin II-mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for angiotensin II-mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for angiotensin II-mediated diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875557